Kymera
what we hope you will take from today targeted protein degradation is positioned to transform drug development landscape is a medicine focused company with recognized leadership in we employ a novel and differentiated scientific strategy and approach around target selection drug development and platform investments we are committed to innovation execution and to the pursuit of real step change in treatment paradigms there is much we have accomplished since our founding but even more we expect to deliver in and beyond we have a very ambitious but achievable vision for the company | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
104 of 105
Related slides by other companies
Alkermes
Investor Conference
January 2024
proven drug development capabilities | Alkermes
AbCellera
Investor Conference
April 2023
drug development has three steps | AbCellera
Genetron
Results
June 2022
in drug development services for i a | Genetron
Certara
Investor Day
December 2021
virtual drug development for a neglected tropical disease | Certara
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io